
The Medicare Prescription Cap
Prescription cap changes
Other spending caps
In Medicare, two types of plans cover prescription drugs: stand-alone Medicare Part D plans or Medicare Advantage prescription drug (MAPD) plans.
Private insurers manage both types of plans, which means the plans have different deductibles, premiums, and coinsurances.
But due to the Inflation Reduction Act of 2022, once coverage kicks in, you don't need to pay more than a fixed amount out of pocket per year.
What is the Medicare prescription cap for 2025?
In 2025, you don't need to pay more than $2,000 per year out of pocket once your drug coverage kicks in. Once you reach this amount, you enter catastrophic coverage.
This means your plan must fully cover any further costs. You can also use any contributions you make toward Extra Help toward this limit.
This annual cap applies to stand-alone Part D and Medicare Advantage (Part C) plans offering drug coverage, also known as MAPD plans.
Does the Medicare prescription cap change annually?
As of 2025, the Medicare prescription cap is significantly lower than in previous years. Before the new law took effect in 2024, you had to spend $8,000 before reaching catastrophic coverage.
You were in the donut hole once you reached $5,030 until you reached $8,000. That said, the new annual cap eliminated this donut hole. However, it isn't static and changes each year. It may rise to $2,100 in 2026.
What other spending caps does Medicare have?
Medicare spending caps are generally called maximum out-of-pocket (MOOP) limits. While MOOP limits don't apply to Original Medicare (parts A and B), they do apply to Part C and D plans in other ways besides your overall, annual spending on prescription drugs.
For example, under the Inflation Reduction Act, any Medicare drug plan enrollees who need insulin may never pay more than $35 per month.
Your plan may have two MOOP limits: one for in-network services and another for out-of-network services. In 2025, you may not spend more than $9,350 for in-network services and no more than $14,000 for out-of-network services.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
18 minutes ago
- Yahoo
House passes Trump's cuts to public broadcasting, foreign aid; next stop president's desk
WASHINGTON − President Donald Trump's push for $9 billion in spending cuts − slicing into public broadcasting stations PBS and NPR, as well as the United States' foreign aid efforts − crossed the Congressional finish line just after midnight on July 18 and soon will hit the Republican's desk for signature into law. The House approved the measure, in response to Trump's official request, in a 216-213 party line vote. Two Republicans voted no on the second-term president's plan, which represents just a fraction of the almost $200 billion that Trump's Department of Government Efficiency claims to have saved the federal government. A bulk of the cuts in the legislation strips away funding authorized by a previous law for foreign aid, including peacekeeping efforts and global health initiatives. More: Elmo and AIDS prevention: What is Congress targeting in their spending cuts? Office of Management and Budget Director Russell Vought said the amounts being slashed represent "wasteful and unnecessary spending," in the White House's formal request to Congress. Around $1 million will be taken from public broadcasting, including PBS and NPR. Local stations, which are much more reliant on federal grants than their national counterparts, are expected to bear the brunt of that lost funding. Congress barely met their July 18 midnight deadline to get the bill approved, otherwise the current funding would remains in place. The Senate passed its version of the spending cut bill earlier in the week after Republicans including Sen. Susan Collins successfully saved funding grants for AIDS prevention . This article originally appeared on USA TODAY: Congress approves Trump's $9 billion cuts to PBS, NPR, foreign aid
Yahoo
18 minutes ago
- Yahoo
Strong earnings and upbeat economic data power stocks to fresh all-time highs
The S&P 500 and Nasdaq hit fresh records on Thursday on strong earnings and economic data. Q2 earnings season is off to a strong start, with 71% of firms beating estimates. Jobless claims also ticked lower while retail sales rose, soothing concerns about the economy. US stocks closed at a record high on Thursday as traders brushed off the latest Trump-Powell drama and took in strong corporate earnings and positive economic data. Major indexes popped a day after a brief spasm of volatility brought on by reports Donald Trump was gearing up to fire Federal Reserve Chairman Jerome Powell. The Dow on Thursday gained more than 200 points. The S&P 500 and Nasdaq 100 each rose more than 0.5%, with both indexes reaching a new closing record. Here's where US indexes stood at the 4 p.m. closing bell on Thursday: S&P 500: 6,297.50, up 0.54% Dow Jones Industrial Average: 44,485.53, up 0.52% (+230.75 points) Nasdaq Composite: 20,884.27, up 0.74% Here's what's powering the latest all-time highs for the stock market. Earnings season Investors have been cheering a strong start to the earnings season, with shares of PepsiCo and United Airlines surging after posting earnings beats. PepsiCo popped 7%, while United Airlines rose as much as 4% Thursday before paring its gains in the afternoon. Financial stocks also climbed, boosted by strong earnings from JPMorgan, Wells Fargo, Morgan Stanley, and Goldman Sachs this week. Out of all S&P 500 companies that have already posted their second-quarter results, 71% have beaten earnings estimates, according to FactSet. The benchmark index is now on track to post more than 9% earnings growth for the quarter, the firm said in an analysis this week. Upbeat data The market was also comforted by signs that the US economy remains on solid footing despite worries about tariffs. Initial jobless claims in the last week fell to 221,000, down by around 7,000 from the prior week, according to the Labor Department. Americans also ramped up their spending more than expected last month. Retail sales rose 0.6% in June, according to the US Census Bureau, beating economists' estimates. Healthy data is smoothing over fears that economic growth will be dented by President Donald Trump's tariffs. "The damage from tariffs can't be found yet," Louis Navellier, the founder of Navellier & Associates, said of retail sales growth in a note on Thursday. "Granted, there is still a long way to go in reaching the final tariff agreements, but the turmoil that some feared is not showing up in the numbers, helping to explain why stocks are at all-time highs." Strong consumer spending, which accounts for around two-thirds of GDP growth, is also bolstering confidence that the US will avoid a recession this year. "Consumers are flexing their spending muscle again," Gina Bolvin, the president of Bolvin Wealth Management Group, wrote in a note. "Strong retail sales are like oxygen for the economy, and Wall Street is breathing a sigh of relief today." Read the original article on Business Insider Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
18 minutes ago
- Yahoo
Weave Announces Date of Second Quarter 2025 Financial Results and Conference Call
LEHI, Utah, July 18, 2025--(BUSINESS WIRE)--Weave (NYSE: WEAV), a leading all-in-one customer experience and payments software platform for small and medium-sized healthcare businesses, today announced it will release its financial results for the second quarter 2025 after U.S. markets close on Thursday, July 31, 2025. Company management will host a conference call and webcast at 4:30 p.m. ET to discuss Weave's financial results and provide a business update. Individuals interested in listening to the conference call may do so by dialing (412) 902-1020 or toll-free at (877) 502-7186. The live webcast and a webcast replay of the conference call can be accessed from the investor relations page of Weave's website at About Weave Weave is the leading all-in-one customer experience and payments software platform for small and medium-sized healthcare businesses. From the first phone call to the final invoice and every touchpoint in between, Weave connects the entire patient journey. Weave's software solutions transform how healthcare practices attract, communicate with, and engage patients and clients to grow their business. Weave seamlessly integrates billing and payment requests into communication workflows, streamlining payment timelines, reducing accounts receivable, and supporting practice profitability. In the past year, Weave has been named an Inc. Power Partner, a G2 leader in Patient Relationship Management software, and a Top 50 Product for Small Business. To learn more, visit View source version on Contacts Investor Contact:Mark McReynoldsHead of Investor Relationsir@ Media Contact:Natalie HouseSenior Director of Content & Communicationspr@